BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18852655)

  • 1. Mimetic human leukocyte antigen epitopes: shown by monoclonal antibodies and extra antibodies produced on transplantation.
    Sasaki N; Idica A; Terasaki PI
    Transplantation; 2008 Oct; 86(7):912-8. PubMed ID: 18852655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
    Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
    Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HLA class I specific antibodies in patients with failed allografts.
    Mao Q; Terasaki PI; Cai J; El-Awar N; Rebellato L
    Transplantation; 2007 Jan; 83(1):54-61. PubMed ID: 17220791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
    El-Awar NR; Akaza T; Terasaki PI; Nguyen A
    Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II DQ epitopes.
    Deng CT; Cai J; Tarsitani C; El-Awar N; Lachmann N; Ozawa M
    Clin Transpl; 2006; ():115-22. PubMed ID: 18365373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected frequencies of HLA antibody specificities in the sera of pre-transplant kidney patients.
    Idica A; Sasaki N; Hardy S; Terasaki P
    Clin Transpl; 2006; ():161-70. PubMed ID: 18365376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.
    Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ
    Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New HLA class I epitopes defined by murine monoclonal antibodies.
    El-Awar N; Terasaki PI; Nguyen A; Lias M; Conger N
    Hum Immunol; 2010 May; 71(5):456-61. PubMed ID: 20156507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA epitope matching. Contribution of matched residues to epitopes recognized by alloantibodies.
    Akkoc N; Scornik JC
    Transplantation; 1991 Nov; 52(5):903-7. PubMed ID: 1719667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood.
    El-Awar N; Terasaki PI; Nguyen A; Sasaki N; Morales-Buenrostro LE; Saji H; Maruya E; Poli F
    Hum Immunol; 2009 Oct; 70(10):844-53. PubMed ID: 19580837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II DP epitopes.
    Deng CT; Cai J; Ozawa M; El-Awar N
    Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR antibody epitopes.
    Cai J; Kohanof S; Terasaki PI
    Clin Transpl; 2006; ():103-14. PubMed ID: 18365372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public epitopes and the antigenic structure of the HLA molecules.
    Rodey GE; Fuller TC
    Crit Rev Immunol; 1987; 7(3):229-67. PubMed ID: 2441930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.